NCT05147688招募中1 期
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Pulmonary Diseases
The Foundation for Orthopaedics and Regenerative Medicine1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年12月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Safety (adverse events)
研究概览
简要总结
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Pulmonary Diseases
详细描述
In this patient funded trial, patients with pulmonary disease will receive a single intravenous infusion of UC-MSCs. The total dose will be 100 million cells. Patients will be evaluated within one month pre treatment and at 1, 6, 12, 24, 36, and 48 months post treatment for safety and efficacy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of pulmonary disease
- •Understanding and willingness to sign a written informed consent document
排除标准
- •Active infection
- •Active cancer
- •Chronic multisystem organ failure
- •Pregnancy
- •Clinically significant Abnormalities on pre-treatment laboratory evaluation
- •Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
- •Continued drug abuse
- •Pre-menopausal women not using contraception
- •Previous organ transplant
- •Hypersensitivity to sulfur
研究组 & 干预措施
Treatment Group
Experimental
Single intravenous infusion of 100 million cells
干预措施: AlloRx (Biological)
结局指标
主要结局
Safety (adverse events)
时间窗: Four year follow-up
Clinical monitoring of possible adverse events or complications
次要结局
- Efficacy: Pulmonary function test(Four year follow-up)
- Efficacy: Forced vital capacity (FVC)(Four year follow-up)
研究者
研究点 (1)
Loading locations...
相似试验
撤回
1 期
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette SyndromeTourette SyndromeNCT05158439The Foundation for Orthopaedics and Regenerative Medicine
招募中
1 期
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for AutismAutismNCT05003960The Foundation for Orthopaedics and Regenerative Medicine15
招募中
1 期
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKDChronic Kidney DiseasesNCT05018845The Foundation for Orthopaedics and Regenerative Medicine20
终止
1 期
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for DiabetesDiabetesNCT05003908The Foundation for Orthopaedics and Regenerative Medicine2
招募中
1 期
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for LupusLupusNCT05018858The Foundation for Orthopaedics and Regenerative Medicine15